At Duality and at Team8 Health, data scientists and industry experts work every day to introduce innovation that can help solve these issues - in this case enable authorized users the ability to conduct advanced analytics on linked genomic and clinical data. To explore the different aspects of genomic data sharing, biopharmaceutical data sharing and analysis, and the powerful outcomes that can be reached by linking different types of sensitive health data, Duality’s CEO and Co-founder Dr. Alon Kaufman and Team8 Health Managing Partner Dr. Kinneret Livnat-Savitzky sat down in the Team8 office to discuss how privacy enhancing technologies, machine learning & AI can help.